|
1
|
Radiotherapy in breast-conserving treatment for ductal carcinoma in situ: first results of the EORTC randomised phase III trial 10853. EORTC Breast Cancer Cooperative Group and EORTC Radiotherapy Group.
|
Lancet
|
2000
|
6.07
|
|
2
|
Neu-protein overexpression in breast cancer. Association with comedo-type ductal carcinoma in situ and limited prognostic value in stage II breast cancer.
|
N Engl J Med
|
1988
|
4.06
|
|
3
|
Randomised trial of high-dose chemotherapy and haemopoietic progenitor-cell support in operable breast cancer with extensive axillary lymph-node involvement.
|
Lancet
|
1998
|
3.06
|
|
4
|
Ductal carcinoma in situ: a proposal for a new classification.
|
Semin Diagn Pathol
|
1994
|
2.92
|
|
5
|
Refinement of breast cancer classification by molecular characterization of histological special types.
|
J Pathol
|
2008
|
2.73
|
|
6
|
Ductal carcinoma in-situ of the breast; second EORTC consensus meeting.
|
Eur J Cancer
|
1992
|
2.67
|
|
7
|
[The treatment of ductal carcinoma in situ (DCIS) of the breast].
|
Ned Tijdschr Geneeskd
|
2003
|
2.67
|
|
8
|
Risk factors for recurrence and metastasis after breast-conserving therapy for ductal carcinoma-in-situ: analysis of European Organization for Research and Treatment of Cancer Trial 10853.
|
J Clin Oncol
|
2001
|
2.51
|
|
9
|
Reduction in the number of sentinel lymph node procedures by preoperative ultrasonography of the axilla in breast cancer.
|
Eur J Cancer
|
2003
|
2.40
|
|
10
|
[Dutch Institute for Healthcare Improvement guideline, "Treatment of breast cancer"].
|
Ned Tijdschr Geneeskd
|
2002
|
2.39
|
|
11
|
Differences in risk factors for local and distant recurrence after breast-conserving therapy or mastectomy for stage I and II breast cancer: pooled results of two large European randomized trials.
|
J Clin Oncol
|
2001
|
2.28
|
|
12
|
Simultaneous loss of E-cadherin and catenins in invasive lobular breast cancer and lobular carcinoma in situ.
|
J Pathol
|
1997
|
2.15
|
|
13
|
E-cadherin inactivation in lobular carcinoma in situ of the breast: an early event in tumorigenesis.
|
Br J Cancer
|
1997
|
2.02
|
|
14
|
The impact of tumor size and histology on local control after breast-conserving therapy.
|
Radiother Oncol
|
1988
|
1.83
|
|
15
|
Randomized trial of high-dose chemotherapy and hematopoietic progenitor-cell support in operable breast cancer with extensive lymph node involvement: final analysis with 7 years of follow-up.
|
Ann Oncol
|
2002
|
1.80
|
|
16
|
Reliability of sentinel lymph node biopsy for staging melanoma.
|
Br J Surg
|
2000
|
1.71
|
|
17
|
Histological determinants for different types of local recurrence after breast-conserving therapy of invasive breast cancer. Dutch Study Group on local Recurrence after Breast Conservation (BORST)
|
Eur J Cancer
|
1999
|
1.55
|
|
18
|
Amplification of genes within the chromosome 11q13 region is indicative of poor prognosis in patients with operable breast cancer.
|
Cancer Res
|
1992
|
1.53
|
|
19
|
Breast cancer response to neoadjuvant chemotherapy: predictive markers and relation with outcome.
|
Br J Cancer
|
2003
|
1.50
|
|
20
|
Causes of inconsistency in diagnosing and classifying intraductal proliferations of the breast. European Commission Working Group on Breast Screening Pathology.
|
Eur J Cancer
|
2000
|
1.50
|
|
21
|
Clear cell sarcoma (malignant melanoma) of soft parts: A clinicopathologic study of 30 cases.
|
Cancer
|
1999
|
1.46
|
|
22
|
Validation of 70-gene prognosis signature in node-negative breast cancer.
|
Breast Cancer Res Treat
|
2008
|
1.45
|
|
23
|
Variations in diagnostic and therapeutic procedures in a multicentre, randomized clinical trial (EORTC 10853) investigating breast-conserving treatment for DCIS.
|
Eur J Surg Oncol
|
2001
|
1.44
|
|
24
|
[Diagnostics in clinically occult, radiologically suspect breast lesions more often surgery than needle diagnostics with image monitoring].
|
Ned Tijdschr Geneeskd
|
2001
|
1.43
|
|
25
|
[Identification of the sentinel node in patients with breast carcinoma].
|
Ned Tijdschr Geneeskd
|
1996
|
1.42
|
|
26
|
[Detailed pathological examination of the sentinel lymph nodes in order to detect micrometastases: no clinical relevance in patients with breast cancer].
|
Ned Tijdschr Geneeskd
|
2004
|
1.40
|
|
27
|
[Tumor markers in screening, diagnosis and treatment of patients with breast carcinoma].
|
Ned Tijdschr Geneeskd
|
1993
|
1.38
|
|
28
|
Lymphoepithelioma-like carcinoma of the breast: lack of evidence of Epstein-Barr virus infection.
|
Histopathology
|
2001
|
1.32
|
|
29
|
Pathological work-up of sentinel lymph nodes in breast cancer. Review of current data to be considered for the formulation of guidelines.
|
Eur J Cancer
|
2003
|
1.31
|
|
30
|
Expression of oestrogen receptor and loss of E-cadherin are diagnostic for gastric metastasis of breast carcinoma.
|
Histopathology
|
2005
|
1.27
|
|
31
|
Consistency achieved by 23 European pathologists from 12 countries in diagnosing breast disease and reporting prognostic features of carcinomas. European Commission Working Group on Breast Screening Pathology.
|
Virchows Arch
|
1999
|
1.24
|
|
32
|
Acinic cell carcinoma of the breast: an immunohistochemical and ultrastructural study.
|
Virchows Arch
|
2000
|
1.24
|
|
33
|
Histological type and marker expression of the primary tumour compared with its local recurrence after breast-conserving therapy for ductal carcinoma in situ.
|
Br J Cancer
|
2001
|
1.22
|
|
34
|
The expression pattern of MUC1 (EMA) is related to tumour characteristics and clinical outcome of invasive ductal breast carcinoma.
|
Histopathology
|
2007
|
1.21
|
|
35
|
Evidence for a gene on 17p13.3, distal to TP53, as a target for allele loss in breast tumors without p53 mutations.
|
Cancer Res
|
1994
|
1.21
|
|
36
|
No common denominator for breast cancer lymph node metastasis.
|
Br J Cancer
|
2005
|
1.20
|
|
37
|
Discrepancies in current practice of pathological evaluation of sentinel lymph nodes in breast cancer. Results of a questionnaire based survey by the European Working Group for Breast Screening Pathology.
|
J Clin Pathol
|
2004
|
1.19
|
|
38
|
Consistency of staining and reporting of oestrogen receptor immunocytochemistry within the European Union--an inter-laboratory study.
|
Virchows Arch
|
2004
|
1.19
|
|
39
|
Frozen section investigation of the sentinel node in malignant melanoma and breast cancer.
|
Ann Surg Oncol
|
2001
|
1.19
|
|
40
|
Diagnostic accuracy for different strategies of image-guided breast intervention in cases of nonpalpable breast lesions.
|
Br J Cancer
|
2004
|
1.18
|
|
41
|
Immunohistochemical categorisation of ductal carcinoma in situ of the breast.
|
Br J Cancer
|
2007
|
1.17
|
|
42
|
Prognosis after treatment for loco-regional recurrence after mastectomy or breast conserving therapy in two randomised trials (EORTC 10801 and DBCG-82TM). EORTC Breast Cancer Cooperative Group and the Danish Breast Cancer Cooperative Group.
|
Eur J Cancer
|
1999
|
1.17
|
|
43
|
Genetic alterations on chromosome 16 and 17 are important features of ductal carcinoma in situ of the breast and are associated with histologic type.
|
Br J Cancer
|
1999
|
1.17
|
|
44
|
Breast-conserving therapy for Paget disease of the nipple: a prospective European Organization for Research and Treatment of Cancer study of 61 patients.
|
Cancer
|
2001
|
1.16
|
|
45
|
In-situ breast cancer: the EORTC consensus meeting.
|
Lancet
|
1989
|
1.13
|
|
46
|
Localizing the sentinel node in cutaneous melanoma: gamma probe detection versus blue dye.
|
Ann Surg Oncol
|
1997
|
1.13
|
|
47
|
Long-term prognosis of patients with local recurrence after conservative surgery and radiotherapy for early breast cancer.
|
Eur J Cancer
|
2005
|
1.10
|
|
48
|
Phosphorylation of the oestrogen receptor alpha at serine 305 and prediction of tamoxifen resistance in breast cancer.
|
J Pathol
|
2009
|
1.09
|
|
49
|
Toker cells are probably precursors of Paget cell carcinoma: a morphological and ultrastructural description.
|
Virchows Arch
|
2002
|
1.09
|
|
50
|
Cyclin D1 gene amplification and overexpression are present in ductal carcinoma in situ of the breast.
|
J Pathol
|
1999
|
1.08
|
|
51
|
Efficacy of high-dose alkylating chemotherapy in HER2/neu-negative breast cancer.
|
Ann Oncol
|
2006
|
1.08
|
|
52
|
Alveolar soft part sarcoma. a report of 15 cases.
|
Eur J Cancer
|
2002
|
1.08
|
|
53
|
Primary axillary radiotherapy as axillary treatment in breast-conserving therapy for patients with breast carcinoma and clinically negative axillary lymph nodes.
|
Cancer
|
2000
|
1.07
|
|
54
|
Immunohistochemical detection of the neu protein in tissue sections of human breast tumors with amplified neu DNA.
|
Oncogene
|
1988
|
1.05
|
|
55
|
Malignant neoplasms infiltrating pseudoangiomatous' stromal hyperplasia of the breast: an unrecognized pathway of tumour spread.
|
Histopathology
|
2002
|
1.04
|
|
56
|
Consistency achieved by 23 European pathologists in categorizing ductal carcinoma in situ of the breast using five classifications. European Commission Working Group on Breast Screening Pathology.
|
Hum Pathol
|
1998
|
1.04
|
|
57
|
The impact of preoperative MRI on breast-conserving surgery of invasive cancer: a comparative cohort study.
|
Breast Cancer Res Treat
|
2008
|
1.02
|
|
58
|
Photodynamic therapy as adjuvant therapy in surgically treated pleural malignancies.
|
Br J Cancer
|
1997
|
1.02
|
|
59
|
Interobserver variability between general and expert pathologists during the histopathological assessment of large-core needle and open biopsies of non-palpable breast lesions.
|
Eur J Cancer
|
2003
|
1.00
|
|
60
|
Effects of patient selection on the applicability of results from a randomised clinical trial (EORTC 10853) investigating breast-conserving therapy for DCIS.
|
Br J Cancer
|
2002
|
0.99
|
|
61
|
Malignant schwannoma of the parapharyngeal space in von Recklinghausen's disease: a case report and review of the literature.
|
J Laryngol Otol
|
1993
|
0.99
|
|
62
|
Solitary fibrous tumour (myofibroblastoma) of the breast.
|
Virchows Arch
|
1994
|
0.99
|
|
63
|
Lymphatic mapping and sentinel lymph node biopsy in breast cancer.
|
Eur J Nucl Med
|
1999
|
0.97
|
|
64
|
Risk of invasion and axillary lymph node metastasis in ductal carcinoma in situ diagnosed by core-needle biopsy.
|
Br J Surg
|
2007
|
0.92
|
|
65
|
Eight false negative sentinel node procedures in breast cancer: what went wrong?
|
Eur J Surg Oncol
|
2003
|
0.91
|
|
66
|
The correlation of mammographic-and histologic patterns of breast cancers in BRCA1 gene mutation carriers, compared to age-matched sporadic controls.
|
Eur Radiol
|
2006
|
0.89
|
|
67
|
Lymphatic mapping with intralesional tracer administration in breast carcinoma patients.
|
Cancer
|
2000
|
0.89
|
|
68
|
Impact of non-axillary sentinel node biopsy on staging and treatment of breast cancer patients.
|
Br J Cancer
|
2002
|
0.89
|
|
69
|
Mammographically detected in situ lobular carcinomas of the breast.
|
Virchows Arch
|
2000
|
0.88
|
|
70
|
Polyploidy in pleomorphic adenomas with cytological atypia.
|
Cytopathology
|
1992
|
0.86
|
|
71
|
Hormone replacement therapy, mammography screening and changing age-specific incidence rates of breast cancer: an ecological study comparing two European populations.
|
Breast Cancer Res Treat
|
2007
|
0.86
|
|
72
|
Amplification and over-expression of the neu oncogene in human breast carcinomas.
|
Eur J Surg Oncol
|
1988
|
0.86
|
|
73
|
Ductal carcinoma in situ.
|
Lancet
|
1994
|
0.85
|
|
74
|
Bilateral angiosarcoma of the breast after conservative treatment of bilateral invasive carcinoma: genetic predisposition?
|
Eur J Surg Oncol
|
2002
|
0.85
|
|
75
|
Local recurrence of a phyllodes tumour of the breast presenting with widespread differentiation to a telangiectatic osteosarcoma.
|
J Clin Pathol
|
1998
|
0.85
|
|
76
|
CSF cytology versus immunocytochemistry in meningeal carcinomatosis.
|
J Neurol Neurosurg Psychiatry
|
1988
|
0.85
|
|
77
|
Keratin immunoreactivity in melanoma of soft parts (clear cell sarcoma).
|
Histopathology
|
1995
|
0.85
|
|
78
|
The expression pattern of MUC1 (EMA) is related to tumour characteristics and clinical outcome in 'pure' ductal carcinoma in situ of the breast.
|
Histopathology
|
2007
|
0.84
|
|
79
|
Is lymphatic mapping in breast cancer adequate and safe?
|
World J Surg
|
2001
|
0.84
|
|
80
|
Feasibility study of FEC-chemotherapy with dose-intensive epirubicin as initial treatment in high-risk breast cancer.
|
Ann Oncol
|
1993
|
0.84
|
|
81
|
Cytodiagnosis of non-Hodgkin's lymphoma. A morphological analysis of 215 biopsy proven cases.
|
Virchows Arch A Pathol Anat Histopathol
|
1984
|
0.84
|
|
82
|
Ischemic duodenitis without involvement of the large abdominal arteries.
|
Endoscopy
|
2007
|
0.84
|
|
83
|
[A patient with a parathyroid carcinoma].
|
Ned Tijdschr Geneeskd
|
1986
|
0.83
|
|
84
|
[In-situ ductal carcinoma of the breast; a retrospective clinico-pathological study].
|
Ned Tijdschr Geneeskd
|
1986
|
0.82
|
|
85
|
The incidence and significance of micrometastases in lymph nodes of patients with ductal carcinoma in situ and T1a carcinoma of the breast.
|
Eur J Surg Oncol
|
2006
|
0.82
|
|
86
|
The influence of tamoxifen treatment on the oestrogen receptor in metachronous contralateral breast cancer.
|
Br J Cancer
|
2003
|
0.82
|
|
87
|
Adenomyoepithelioma of the breast associated with low-grade adenosquamous and sarcomatoid carcinomas.
|
Virchows Arch
|
1995
|
0.82
|
|
88
|
False negative sentinel node procedure established through palpation of the biopsy wound.
|
Eur J Surg Oncol
|
2000
|
0.82
|
|
89
|
Prognostic value of DNA ploidy using flow cytometry in 1301 breast cancer patients: results of the prospective Multicenter Morphometric Mammary Carcinoma Project.
|
Mod Pathol
|
1997
|
0.81
|
|
90
|
Low risk of locoregional recurrence of primary breast carcinoma after treatment with a modification of the Halsted radical mastectomy and selective use of radiotherapy.
|
Cancer
|
1999
|
0.81
|
|
91
|
Increased proliferative activity and p53 expression in normal glandular breast tissue after radiation therapy.
|
J Pathol
|
1998
|
0.80
|
|
92
|
Changing patterns in diagnosis and treatment of ductal carcinoma in situ of the breast.
|
Eur J Surg Oncol
|
2005
|
0.80
|
|
93
|
Breast-conserving therapy for invasive carcinoma: diagnosis of local recurrence.
|
Neth J Surg
|
1991
|
0.79
|
|
94
|
Impact of mammographic interval on stage and survival after the diagnosis of contralateral breast cancer.
|
Br J Surg
|
2001
|
0.78
|
|
95
|
Efficacy of up-front 5-fluorouracil-epidoxorubicin-cyclophosphamide (FEC) chemotherapy with an increased dose of epidoxorubicin in high-risk breast cancer patients.
|
Br J Cancer
|
1996
|
0.78
|
|
96
|
Quiz case. Mesenteric panniculitis (sclerosing mesenteritis, mesenteric lipodystrophy, retractile or liposclerotic mesenteritis.
|
Eur J Radiol
|
2001
|
0.78
|
|
97
|
Microcalcifications in ductal carcinoma in situ of the breast: histochemical and immunohistochemical study.
|
Hum Pathol
|
1996
|
0.78
|
|
98
|
Progress in molecular biology of breast cancer.
|
Eur J Cancer
|
1992
|
0.78
|
|
99
|
The value of Cloquet's node in predicting melanoma nodal metastases in the pelvic lymph node basin.
|
Ann Surg Oncol
|
2001
|
0.78
|
|
100
|
Improved staging of breast cancer through lymphatic mapping and sentinel node biopsy.
|
Eur J Surg Oncol
|
1998
|
0.78
|
|
101
|
Reliability of fine needle aspiration cytology for distinguishing between carcinoma, lymphoma and sarcoma; the influence of clinical information.
|
Cytopathology
|
1993
|
0.76
|
|
102
|
The value of needle localised biopsy for diagnosis and treatment of non-palpable screen detected breast cancer.
|
Eur J Surg Oncol
|
2004
|
0.75
|
|
103
|
Iododeoxyuridine labelling of S-phase fraction in fine needle aspirates from breast carcinomas.
|
J Clin Pathol
|
1996
|
0.75
|
|
104
|
[An innocuous prolonged unilateral nose blockage?].
|
Ned Tijdschr Geneeskd
|
1997
|
0.75
|
|
105
|
[The role of sentinel node biopsies in the treatment of patients with breast carcinoma].
|
Ned Tijdschr Geneeskd
|
1996
|
0.75
|
|
106
|
[Good results in periodic screening in women with increased risk of breast cancer; retrospective study].
|
Ned Tijdschr Geneeskd
|
1995
|
0.75
|
|
107
|
[Immunodiagnosis using monoclonal antibodies in patients with occult primary tumors].
|
Ned Tijdschr Geneeskd
|
1983
|
0.75
|
|
108
|
[Adjuvant treatment of breast carcinoma].
|
Ned Tijdschr Geneeskd
|
1993
|
0.75
|
|
109
|
[Results of preoperative radiotherapy in patients with a local fixed rectal carcinoma].
|
Ned Tijdschr Geneeskd
|
1986
|
0.75
|
|
110
|
[Angiosarcoma of the breast].
|
Ned Tijdschr Geneeskd
|
1985
|
0.75
|
|
111
|
Which cytological criteria are the most discriminative to distinguish carcinoma, lymphoma, and soft-tissue sarcoma? A probabilistic approach.
|
Diagn Cytopathol
|
1997
|
0.75
|
|
112
|
Breast-conserving therapy of ductal carcinoma in situ: frequency of local recurrence after wide excision with and without additional radiotherapy, a retrospective study of 42 cases.
|
Neth J Surg
|
1991
|
0.75
|
|
113
|
Downstaging of an advanced gastrointestinal stromal tumor by neoadjuvant imatinib.
|
Dig Surg
|
2004
|
0.75
|
|
114
|
Surgical treatment and deciding definitive management policy in a premenopausal patient with early breast cancer.
|
Eur J Surg Oncol
|
1994
|
0.75
|
|
115
|
Ductal carcinoma in situ of the breast; diagnostic assessment and treatment.
|
Scand J Surg
|
2002
|
0.75
|
|
116
|
[Loco-regional treatment of breast carcinoma].
|
Ned Tijdschr Geneeskd
|
1993
|
0.75
|
|
117
|
Recurrence after breast ablation for ductal carcinoma in situ.
|
Eur J Surg Oncol
|
1992
|
0.75
|
|
118
|
Ductal carcinoma in situ (DCIS) of the breast--a therapeutic dilemma.
|
Eur J Surg Oncol
|
1987
|
0.75
|
|
119
|
Breast cancer: a study into the value of a historical group as comparative material for new methods of treatment.
|
Eur J Surg Oncol
|
1992
|
0.75
|
|
120
|
Sex steroid receptor expression in 'carcinoid' tumours of the breast.
|
Breast Cancer Res Treat
|
1996
|
0.75
|
|
121
|
The relationship between findings on pre-treatment mammograms and local recurrence after breast-conserving therapy for invasive breast cancer.
|
Eur J Surg Oncol
|
1999
|
0.75
|
|
122
|
Third meeting of the DCIS Working Party of the EORTC (Fondazione Cini, Isola S. Giorgio, Venezia, 28 February 1994)--Conference report.
|
Eur J Cancer
|
1994
|
0.75
|
|
123
|
[Steroid hormone receptors and breast carcinoma].
|
Ned Tijdschr Geneeskd
|
1992
|
0.75
|
|
124
|
[Breast-preserving treatment in patients with stage I and II breast carcinoma].
|
Ned Tijdschr Geneeskd
|
1988
|
0.75
|
|
125
|
[Guidelines for pathology--supplement to European guidelines for quality assurance in mammography screening. Report by the Pathology Working Group of the European Community].
|
Pathologe
|
1997
|
0.75
|
|
126
|
[Local recurrence following breast-conserving therapy in breast carcinoma].
|
Ned Tijdschr Geneeskd
|
1989
|
0.75
|